WIM
CLB icon

Waverton Investment Management’s Core Laboratories CLB Stock Holding History

Waverton Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-13,430
Closed -$2.27M – 168
2013
Q3 		$2.27M Buy
+13,430
New +$2.08M 0.13% 129

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Waverton Investment Management's CLB Position: Q4 2013 in Review

Waverton Investment Management sold out of Core Laboratories (CLB) in Q4 2013, closing a stake of 13,430 shares — an estimated $2.27M sold.

Waverton Investment Management first reported a position in CLB in Q3 2013 and held it in 1 quarter. The position peaked at $2.27M in Q3 2013. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2013.

  • Waverton Investment Management reported no remaining Core Laboratories position as of Q4 2013 after selling out during the quarter.
  • Waverton Investment Management sold 13,430 Core Laboratories shares in Q4 2013, an estimated $2.27M.
  • Waverton Investment Management first reported a position in Core Laboratories in Q3 2013 and held it in 1 quarter.
  • Waverton Investment Management's Core Laboratories position peaked at $2.27M in Q3 2013.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2013.

Based on Waverton Investment Management's 13F filing for Q4 2013, filed 21 Jan 2014.